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This year’s Albert Lasker Basic Medical Research Award honors Evelyn Witkin and Stephen
J. Elledge, two pioneers in elucidating the DNA damage response, whose contributions span
more than 40 years.itkin and Elledge at Graham Walker’s
duction into the National Academy of Sci-
nces in 2013. Photo credit: Gordon Walker.Bacterial or human cells devote signifi-
cant resources to maintain the integrity
of their genomes. Among the most severe
challenges are sources of DNA damage
such as ultraviolet (UV) light and other
chemical agents that alter DNA bases.
Crosslinking of DNA bases creates blocks
to normal DNA replication that must be
removed or bypassed. Genome integrity
is also assaulted by ionizing radiation
and other clastogens that cause double-
strand breaks that must be rejoined,
either by nonhomologous end-joining or
by homologous recombination. For repair
to be successful, it must be completed
before the cell divides; incompletely repli-
cated chromosomes become trapped,
while acentric broken chromosome seg-
ments get lost or mis-segregated. Fail-
ures of the DNA damage response are a
common cause of cancer in humans. To
assure that repair is accomplished before
cell division, cells have evolved complex
surveillance mechanisms to identify DNA
damage, to impose checkpoints that ar-
rest cell division until repair is completed,
and to assure that an appropriate DNA
repair response is launched. This year’s
Lasker prize honors two visionary scien-
tists whose experiments and revolution-
ary insights set the stage for our present
understanding of these critical processes.
Evelyn Witkin’s contributions to the
field of DNA repair began with her first
publication, in 1946, identifying a mutant
E. coli strain that is resistant to both UV
light and X-rays. She noted that this strain
does not show the usual delay in cell divi-
sion or the filamentous elongation before
cell division that is normally seen in wild-
type strains. Subsequently, she noted
many similarities between UV-induced
filament formation and the UV-induced
activation of the dormant phage l.
After moving from Cold Spring HarborLaboratory to the State University of
New York Downstate Medical Center,
Witkin pursued these ideas while also
providing key insights into the process of
UV-induced mutagenesis, identifying a
‘‘dark repair’’ process in addition to the
photo-reversal of pyrimidine dimers and
suggesting the existence of error-prone
DNA polymerases.
In her seminal paper (Witkin, 1967),
Evelyn Witkin invoked the ideas recently
proposed by Jacob and Monod of a
repressor that inhibits both UV-induced
phenomena and that itself would be inac-
tivated by UV irradiation. By this time, it
was already known that phage l itself
has a repressor that is inactivated by UV
light. Witkin proposed that the presence
of UV photodimers triggers the inactiva-
tion of a common repressor that would
then allow the expression of genes, which
in turn would promote both the arrest
of cell division and the induction of theW
in
eCell 162, Sepphage. Subsequently, Miro Radman, a
postdoctoral fellow in Paris, circulated a
letter in 1971 to leading scientists in
the field, proposing the concept of a gen-
eral ‘‘SOS response.’’ Radman’s ideas
were not formally published and widely
available until 1975, but Witkin quickly
embraced this idea. She summarized the
rapidly growing body of knowledge in a
comprehensive review on ‘‘Ultraviolet
mutagenesis and inducible DNA repair in
Escherichia coli’’ (Witkin, 1976).
Soon afterWitkin advanced her hypoth-
esis, several labs identified key elements
of this regulation. Activation of phage l
and inhibition of cell division depend on
the recombination protein RecA. Witkin
herself, now at Rutgers University,
showed that UV-induced mutagenesis
depends on an apparently UV-induced
error-prone form of DNA replication
controlled by LexA (Witkin and George,
1973), which proved to be the repressor
of many SOS genes. The induction of
phage l depends on the proteolytic cleav-
age of the l repressor, a process involving
RecA. Initially RecA was thought to be a
protease as well as the central recombi-
nation protein, but subsequent work has
shown that RecA, which forms a filament
on single-stranded DNA that is created
at stalled replication forks (i.e., after UV
irradiation) or on the resected single-
stranded ends of X-ray broken DNA
ends, acts as an allosteric effector to pro-
mote the autocleavage of both LexA and
the l repressor.
In the more than 40 years sinceWitkin’s
hypothesis began to take molecular
shape, the SOS response has emerged
as a much more complex network of re-
sponses to DNA damage. Nearly 70
genes have been identified that either
regulate LexA response or are regulated
directly by LexA and are induced bytember 10, 2015 ª2015 Elsevier Inc. 1183
DNA damage. These genes have been
identified by reporter gene fusions to
various promoters and subsequently by
gene expression profiling or by bioinfor-
matics approaches using the consensus
SOS repressor sequence. Among the pro-
cesses controlled by SOS are cell divi-
sion, nucleotide excision repair, DNA
repair by recombination, and translesion
DNA polymerases. Witkin’s decisive role
in understanding the bacterial DNA dam-
age response has been recognized by
many awards, most notably the National
Medal of Science in 2004.
Oneparticular LexA-regulated ‘‘bypass’’
DNApolymerase, encodedby theUmuDC
operon, provides the link between Evelyn
Witkin and Stephen Elledge. Witkin had
generously supported the research of
young researchers such as Graham
Walker (in his case, Witkin carried a sensi-
tive UV dose meter from Paris to Cam-
bridge, MA, so that Walker could carry
out his experiments). Elledge and Walker
(Elledge and Walker, 1983) cloned the
UmuC and UmuD open reading frames.
UmuD is cleaved in a RecA-dependent
fashion to a smaller, active form called
UmuD0. Witkin herself showed that there
is a third key RecA-mediated activity, in-
dependent of the operon’s induction by
LexA or the cleavage of UmuD.
In Walker’s lab, Elledge first displayed
his remarkable facility in creating novel
genetic screens and molecular tools
for the analysis of complex regulation, in-
venting phasmid vectors for the comple-
mentation of E. coli mutants. Indeed,
throughout his career, Elledge has in-
vented remarkable research tools and ge-
netic screens, most recently a powerful
new method for profiling human popula-
tions with a drop of blood, using a syn-
thetic human virome to detect anti-viral
antibodies.
After earning his Ph.D., Elledge moved
to Ron Davis’ lab at Stanford for his post-
doctoral work, making the transition from
prokaryotes to the emerging eukaryotic
model system, budding yeast. Elledge’s
initial goal was to use phage-expression
techniques to screen for yeast’s RecA
on the assumption that an anti-RecA
antibody would find the gene. Instead,
he accidentally pulled out the gene en-
coding the small subunit of ribonucleotide
reductase, Rnr2 (Elledge and Davis,
1987). (It would take another 5 years1184 Cell 162, September 10, 2015 ª2015 Elbefore yeast’s Rad51 protein would be
shown to be similar to RecA.) Elledge
demonstrated that RNR2 mRNA is
strongly induced by DNA damage and
realized that this might be a tool through
which he could interrogate the regu-
latory pathway responsible for RNR2’s
induction.
Elledge’s characterization of RNR2
regulation quickly established that it
does not fit the paradigm of the E. coli
response: its expression is still induced
by UV in the absence of protein synthesis.
A 42-bp regulatory region would confer
damage inducibility to a reporter gene
but does not share sequence similarity
with the LexA binding site. Importantly, a
protein kinase, Dun1, was found to be a
key regulator of RNR gene expression af-
ter blocking DNA replication (Zhou and El-
ledge, 1993). Dun1 itself is activated for
autophosphorylation in response to DNA
damage. This finding established that
DNA damage is indeed transduced by
signal transduction, through a protein ki-
nase, and was the first demonstration of
what is now called the DNA damage
response (DDR) pathway.
The concept of a DNA-damage-depen-
dent cell-cycle delay in eukaryotes was
intuited by Tobey (Tobey, 1975) studying
drug and UV-sensitive mutants in fission
yeast, and the concept of a DNA damage
checkpoint was first articulated by Wei-
nert and Hartwell (Weinert and Hartwell,
1988), who demonstrated that mutants
in the RAD9 gene, while proficient for
repair of X-ray induced lesions, are X-ray
sensitive because they fail to arrest prior
to mitosis and thus give cells sufficient
time to repair lesions before chromosome
segregation. Several additional muta-
tions, including mutants in MEC1 (mitotic
entry checkpoint) and RAD53 (originally
identified as an X-ray sensitive mutation),
had been identified by Weinert et al.
(Weinert et al., 1994), but the biochemical
activities of these gene products were un-
known. Elledge’s lab contemporaneously
identified S-phase arrest-defective (sad)
mutants, including an allele of RAD53
and an allele ofMEC1, which later proved
to be yeast’s homolog of the ATR kinase
(Allen et al., 1994). Allen et al. showed first
that Rad53 is itself a protein kinase. Sec-
ond, Rad53’s kinase activity is required
for the activation of Dun1, and Dun1 re-
mains unphosphorylated in the rad53sevier Inc.mutant. Third, Rad53 is involved in the
control of three distinct checkpoints: a
pause in G1 after DNA damage, the failure
to induce RNR genes in response to a
replication block, and a failure to delay
mitosis in the face of unrepaired DNA
damage. At this point, it became clear
that the response to DNA damage in eu-
karyotes was not going to be similar to
the regulation of the LexA repressor. The
studies of eukaryotic regulation ‘‘impli-
cate protein phosphorylation in the
cellular response to DNA damage and
replication blocks’’ (Allen et al., 1994).
Indeed, the notion of a cascadeof phos-
phorylation signals, and the counter-
acting dephosphorylations that must
help terminate the checkpoint response,
is the primary theme of eukaryotic cell-
cycle regulation in response to DNA dam-
age. On top of this scheme is another
feature especially of higher eukaryotes,
the self-destruction of cells with DNA
damage by apoptosis, mediated princi-
pally through the p53 gene.
When Elledge set up his own lab at
Baylor College of Medicine in 1989, he
soon began to work on mammalian cells
as well as yeast, embracing questions of
the role of cyclin-dependent kinases in
cell-cycle control. The yeast work quickly
informed recent discoveries in the DNA
damage response in mammalian cells.
Soon thereafter, Elledge’s lab showed
that Mec1 and another kinase Tel1 phos-
phorylate and regulate Rad53 (Sanchez
et al., 1996) and later that Tel1 phosphory-
lates yet another protein kinase Chk1.
In collaboration with Errol Friedberg’s
lab, they established thatMec1 is a homo-
log of the mammalian ATM gene, whose
mutant cells show many defects in
response to DNA damage. In fact, Mec1
later proved to be the homolog of another
PI3K-like kinase, ATR, while Tel1 is the
closer homolog to the ATM-related ATR
gene. As the work progressed, it became
evident that the PI3K-like kinases Mec1
andTel1 sat atopaprotein kinasecascade
whose immediate downstream targets
include Rad53 and Chk1 (Matsuoka
et al., 1998). In a flurry of other papers,
the Elledge lab demonstrated the parallels
between the Mec1/Tel1 regulation of
Rad53 and Chk1 with the mammalian
ATM/ATR control of Chk1 and Rad53’s
mammalian homolog, Chk2, respectively
(Liu et al., 2000; Matsuoka et al., 1998;
Sanchez et al., 1999). The link between
ATR and cell-cycle control became
stronger when Elledge’s lab, in collabo-
ration with Helen Piwnica-Worms,
demonstrated that Chk1 phosphorylates
the key Cdk2 regulator, Cdc25 phospha-
tase (Sanchez et al., 1997), and later,
with Elledge’s long-time collaborator
Wade Harper, showed that this phos-
phorylation triggers the degradation of
Cdc25 and imposes cell-cycle arrest
(Jin et al., 2003). Of course, while cele-
brating Stephen Elledge, it is important
to remember that there were many
important contributions by other labs as
these ideas blossomed. To cite only a
few, Yosef Shiloh’s group first cloned
and sequenced ATM; Michael Kastan
demonstrated a key control by ATM of
p53; Antony Carr and Karlene Cimprich
characterized ATR; and Paul Russell
and Paul Nurse outlined the phospho-
regulation of the Cdk2 kinase.
The outlines of the full DDR are still be-
ing inked in. After moving toHarvardMed-
ical School, Elledge’s lab continued to
enlarge the domain of DDR responses. A
phosphoproteomic screen identified
more than 700 in vivo substrates of ATM
and ATR, implicating ATM/ATR control
of processes as diverse as kinetochorefunction, regulation of the cytoskeleton,
control of ubiquitylation, and protein
degradation by both the proteasome
and autophagy. Most recently, his lab
has carried out an analysis of proteins re-
cruited to DNA-damaged chromatin and a
quantitative ‘‘atlas’’ of ubiquitylation and
acetylation associated with the DDR. In
addition, Elledge’s masterful reviews
have guided the field. Stephen Elledge’s
insights into the eukaryotic DNA damage
response have led to many awards,
most recently the Rosenstiel Award and
the Canada Gairdner Award in 2013.
Both bacteria and eukaryotes exhibit a
complex DDR, but this is one of those
fascinating instances in which there has
been little evolutionary conservation of
the mechanisms to achieve a common
goal. Our present understanding of these
processes owes much to Evelyn Witkin
and Stephen Elledge, the two winners of
this year’s Albert Lasker Award in Basic
Medical Research.REFERENCES
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